Global Biosimilars Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Biosimilars Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report is a detailed and comprehensive analysis for global Biosimilars Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biosimilars Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biosimilars Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biosimilars Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biosimilars Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilars Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilars Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius and Innovent Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biosimilars Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biosimilars Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilars Drug, with revenue, gross margin and global market share of Biosimilars Drug from 2018 to 2023.
Chapter 3, the Biosimilars Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biosimilars Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars Drug.
Chapter 13, to describe Biosimilars Drug research findings and conclusion.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report is a detailed and comprehensive analysis for global Biosimilars Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biosimilars Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biosimilars Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biosimilars Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biosimilars Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilars Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilars Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius and Innovent Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biosimilars Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal Antibodies
- Insulin
- Others
- Hospital
- Retail Pharmacy
- Other
- Qilu Pharmaceutical
- Bio-Thera
- Zhejiang Hisun
- Shanghai Henlius
- Innovent Biologics
- Jiangsu Hengrui
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
- 3SBIO
- Luye Pharma
- Celltrion
- Pfizer
- Novartis
- Dr Reddy’s
- Celgen Biopharma
- Eli Lilly
- Sanofi
- Geropharm
- Biocon
- Wockhardt
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biosimilars Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilars Drug, with revenue, gross margin and global market share of Biosimilars Drug from 2018 to 2023.
Chapter 3, the Biosimilars Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biosimilars Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars Drug.
Chapter 13, to describe Biosimilars Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilars Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilars Drug by Type
1.3.1 Overview: Global Biosimilars Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biosimilars Drug Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Insulin
1.3.5 Others
1.4 Global Biosimilars Drug Market by Application
1.4.1 Overview: Global Biosimilars Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Biosimilars Drug Market Size & Forecast
1.6 Global Biosimilars Drug Market Size and Forecast by Region
1.6.1 Global Biosimilars Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biosimilars Drug Market Size by Region, (2018-2029)
1.6.3 North America Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.6 South America Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biosimilars Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Qilu Pharmaceutical
2.1.1 Qilu Pharmaceutical Details
2.1.2 Qilu Pharmaceutical Major Business
2.1.3 Qilu Pharmaceutical Biosimilars Drug Product and Solutions
2.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.2 Bio-Thera
2.2.1 Bio-Thera Details
2.2.2 Bio-Thera Major Business
2.2.3 Bio-Thera Biosimilars Drug Product and Solutions
2.2.4 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Thera Recent Developments and Future Plans
2.3 Zhejiang Hisun
2.3.1 Zhejiang Hisun Details
2.3.2 Zhejiang Hisun Major Business
2.3.3 Zhejiang Hisun Biosimilars Drug Product and Solutions
2.3.4 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhejiang Hisun Recent Developments and Future Plans
2.4 Shanghai Henlius
2.4.1 Shanghai Henlius Details
2.4.2 Shanghai Henlius Major Business
2.4.3 Shanghai Henlius Biosimilars Drug Product and Solutions
2.4.4 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Henlius Recent Developments and Future Plans
2.5 Innovent Biologics
2.5.1 Innovent Biologics Details
2.5.2 Innovent Biologics Major Business
2.5.3 Innovent Biologics Biosimilars Drug Product and Solutions
2.5.4 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Innovent Biologics Recent Developments and Future Plans
2.6 Jiangsu Hengrui
2.6.1 Jiangsu Hengrui Details
2.6.2 Jiangsu Hengrui Major Business
2.6.3 Jiangsu Hengrui Biosimilars Drug Product and Solutions
2.6.4 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jiangsu Hengrui Recent Developments and Future Plans
2.7 Gan&Lee
2.7.1 Gan&Lee Details
2.7.2 Gan&Lee Major Business
2.7.3 Gan&Lee Biosimilars Drug Product and Solutions
2.7.4 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Gan&Lee Recent Developments and Future Plans
2.8 Tonghua Dongbao
2.8.1 Tonghua Dongbao Details
2.8.2 Tonghua Dongbao Major Business
2.8.3 Tonghua Dongbao Biosimilars Drug Product and Solutions
2.8.4 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Tonghua Dongbao Recent Developments and Future Plans
2.9 United Laboratory
2.9.1 United Laboratory Details
2.9.2 United Laboratory Major Business
2.9.3 United Laboratory Biosimilars Drug Product and Solutions
2.9.4 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 United Laboratory Recent Developments and Future Plans
2.10 3SBIO
2.10.1 3SBIO Details
2.10.2 3SBIO Major Business
2.10.3 3SBIO Biosimilars Drug Product and Solutions
2.10.4 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 3SBIO Recent Developments and Future Plans
2.11 Luye Pharma
2.11.1 Luye Pharma Details
2.11.2 Luye Pharma Major Business
2.11.3 Luye Pharma Biosimilars Drug Product and Solutions
2.11.4 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Luye Pharma Recent Developments and Future Plans
2.12 Celltrion
2.12.1 Celltrion Details
2.12.2 Celltrion Major Business
2.12.3 Celltrion Biosimilars Drug Product and Solutions
2.12.4 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Celltrion Recent Developments and Future Plans
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer Biosimilars Drug Product and Solutions
2.13.4 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer Recent Developments and Future Plans
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Biosimilars Drug Product and Solutions
2.14.4 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Novartis Recent Developments and Future Plans
2.15 Dr Reddy’s
2.15.1 Dr Reddy’s Details
2.15.2 Dr Reddy’s Major Business
2.15.3 Dr Reddy’s Biosimilars Drug Product and Solutions
2.15.4 Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Dr Reddy’s Recent Developments and Future Plans
2.16 Celgen Biopharma
2.16.1 Celgen Biopharma Details
2.16.2 Celgen Biopharma Major Business
2.16.3 Celgen Biopharma Biosimilars Drug Product and Solutions
2.16.4 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Celgen Biopharma Recent Developments and Future Plans
2.17 Eli Lilly
2.17.1 Eli Lilly Details
2.17.2 Eli Lilly Major Business
2.17.3 Eli Lilly Biosimilars Drug Product and Solutions
2.17.4 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Eli Lilly Recent Developments and Future Plans
2.18 Sanofi
2.18.1 Sanofi Details
2.18.2 Sanofi Major Business
2.18.3 Sanofi Biosimilars Drug Product and Solutions
2.18.4 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Sanofi Recent Developments and Future Plans
2.19 Geropharm
2.19.1 Geropharm Details
2.19.2 Geropharm Major Business
2.19.3 Geropharm Biosimilars Drug Product and Solutions
2.19.4 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Geropharm Recent Developments and Future Plans
2.20 Biocon
2.20.1 Biocon Details
2.20.2 Biocon Major Business
2.20.3 Biocon Biosimilars Drug Product and Solutions
2.20.4 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Biocon Recent Developments and Future Plans
2.21 Wockhardt
2.21.1 Wockhardt Details
2.21.2 Wockhardt Major Business
2.21.3 Wockhardt Biosimilars Drug Product and Solutions
2.21.4 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Wockhardt Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilars Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biosimilars Drug by Company Revenue
3.2.2 Top 3 Biosimilars Drug Players Market Share in 2022
3.2.3 Top 6 Biosimilars Drug Players Market Share in 2022
3.3 Biosimilars Drug Market: Overall Company Footprint Analysis
3.3.1 Biosimilars Drug Market: Region Footprint
3.3.2 Biosimilars Drug Market: Company Product Type Footprint
3.3.3 Biosimilars Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilars Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biosimilars Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilars Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Biosimilars Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biosimilars Drug Consumption Value by Type (2018-2029)
6.2 North America Biosimilars Drug Consumption Value by Application (2018-2029)
6.3 North America Biosimilars Drug Market Size by Country
6.3.1 North America Biosimilars Drug Consumption Value by Country (2018-2029)
6.3.2 United States Biosimilars Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Biosimilars Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Biosimilars Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biosimilars Drug Consumption Value by Type (2018-2029)
7.2 Europe Biosimilars Drug Consumption Value by Application (2018-2029)
7.3 Europe Biosimilars Drug Market Size by Country
7.3.1 Europe Biosimilars Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.3 France Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Biosimilars Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilars Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biosimilars Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biosimilars Drug Market Size by Region
8.3.1 Asia-Pacific Biosimilars Drug Consumption Value by Region (2018-2029)
8.3.2 China Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.5 India Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Biosimilars Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biosimilars Drug Consumption Value by Type (2018-2029)
9.2 South America Biosimilars Drug Consumption Value by Application (2018-2029)
9.3 South America Biosimilars Drug Market Size by Country
9.3.1 South America Biosimilars Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Biosimilars Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Biosimilars Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilars Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biosimilars Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biosimilars Drug Market Size by Country
10.3.1 Middle East & Africa Biosimilars Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Biosimilars Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biosimilars Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Biosimilars Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biosimilars Drug Market Drivers
11.2 Biosimilars Drug Market Restraints
11.3 Biosimilars Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilars Drug Industry Chain
12.2 Biosimilars Drug Upstream Analysis
12.3 Biosimilars Drug Midstream Analysis
12.4 Biosimilars Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biosimilars Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilars Drug by Type
1.3.1 Overview: Global Biosimilars Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biosimilars Drug Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Insulin
1.3.5 Others
1.4 Global Biosimilars Drug Market by Application
1.4.1 Overview: Global Biosimilars Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Biosimilars Drug Market Size & Forecast
1.6 Global Biosimilars Drug Market Size and Forecast by Region
1.6.1 Global Biosimilars Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biosimilars Drug Market Size by Region, (2018-2029)
1.6.3 North America Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.6 South America Biosimilars Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biosimilars Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Qilu Pharmaceutical
2.1.1 Qilu Pharmaceutical Details
2.1.2 Qilu Pharmaceutical Major Business
2.1.3 Qilu Pharmaceutical Biosimilars Drug Product and Solutions
2.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.2 Bio-Thera
2.2.1 Bio-Thera Details
2.2.2 Bio-Thera Major Business
2.2.3 Bio-Thera Biosimilars Drug Product and Solutions
2.2.4 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Thera Recent Developments and Future Plans
2.3 Zhejiang Hisun
2.3.1 Zhejiang Hisun Details
2.3.2 Zhejiang Hisun Major Business
2.3.3 Zhejiang Hisun Biosimilars Drug Product and Solutions
2.3.4 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhejiang Hisun Recent Developments and Future Plans
2.4 Shanghai Henlius
2.4.1 Shanghai Henlius Details
2.4.2 Shanghai Henlius Major Business
2.4.3 Shanghai Henlius Biosimilars Drug Product and Solutions
2.4.4 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Henlius Recent Developments and Future Plans
2.5 Innovent Biologics
2.5.1 Innovent Biologics Details
2.5.2 Innovent Biologics Major Business
2.5.3 Innovent Biologics Biosimilars Drug Product and Solutions
2.5.4 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Innovent Biologics Recent Developments and Future Plans
2.6 Jiangsu Hengrui
2.6.1 Jiangsu Hengrui Details
2.6.2 Jiangsu Hengrui Major Business
2.6.3 Jiangsu Hengrui Biosimilars Drug Product and Solutions
2.6.4 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jiangsu Hengrui Recent Developments and Future Plans
2.7 Gan&Lee
2.7.1 Gan&Lee Details
2.7.2 Gan&Lee Major Business
2.7.3 Gan&Lee Biosimilars Drug Product and Solutions
2.7.4 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Gan&Lee Recent Developments and Future Plans
2.8 Tonghua Dongbao
2.8.1 Tonghua Dongbao Details
2.8.2 Tonghua Dongbao Major Business
2.8.3 Tonghua Dongbao Biosimilars Drug Product and Solutions
2.8.4 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Tonghua Dongbao Recent Developments and Future Plans
2.9 United Laboratory
2.9.1 United Laboratory Details
2.9.2 United Laboratory Major Business
2.9.3 United Laboratory Biosimilars Drug Product and Solutions
2.9.4 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 United Laboratory Recent Developments and Future Plans
2.10 3SBIO
2.10.1 3SBIO Details
2.10.2 3SBIO Major Business
2.10.3 3SBIO Biosimilars Drug Product and Solutions
2.10.4 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 3SBIO Recent Developments and Future Plans
2.11 Luye Pharma
2.11.1 Luye Pharma Details
2.11.2 Luye Pharma Major Business
2.11.3 Luye Pharma Biosimilars Drug Product and Solutions
2.11.4 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Luye Pharma Recent Developments and Future Plans
2.12 Celltrion
2.12.1 Celltrion Details
2.12.2 Celltrion Major Business
2.12.3 Celltrion Biosimilars Drug Product and Solutions
2.12.4 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Celltrion Recent Developments and Future Plans
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer Biosimilars Drug Product and Solutions
2.13.4 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer Recent Developments and Future Plans
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Biosimilars Drug Product and Solutions
2.14.4 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Novartis Recent Developments and Future Plans
2.15 Dr Reddy’s
2.15.1 Dr Reddy’s Details
2.15.2 Dr Reddy’s Major Business
2.15.3 Dr Reddy’s Biosimilars Drug Product and Solutions
2.15.4 Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Dr Reddy’s Recent Developments and Future Plans
2.16 Celgen Biopharma
2.16.1 Celgen Biopharma Details
2.16.2 Celgen Biopharma Major Business
2.16.3 Celgen Biopharma Biosimilars Drug Product and Solutions
2.16.4 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Celgen Biopharma Recent Developments and Future Plans
2.17 Eli Lilly
2.17.1 Eli Lilly Details
2.17.2 Eli Lilly Major Business
2.17.3 Eli Lilly Biosimilars Drug Product and Solutions
2.17.4 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Eli Lilly Recent Developments and Future Plans
2.18 Sanofi
2.18.1 Sanofi Details
2.18.2 Sanofi Major Business
2.18.3 Sanofi Biosimilars Drug Product and Solutions
2.18.4 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Sanofi Recent Developments and Future Plans
2.19 Geropharm
2.19.1 Geropharm Details
2.19.2 Geropharm Major Business
2.19.3 Geropharm Biosimilars Drug Product and Solutions
2.19.4 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Geropharm Recent Developments and Future Plans
2.20 Biocon
2.20.1 Biocon Details
2.20.2 Biocon Major Business
2.20.3 Biocon Biosimilars Drug Product and Solutions
2.20.4 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Biocon Recent Developments and Future Plans
2.21 Wockhardt
2.21.1 Wockhardt Details
2.21.2 Wockhardt Major Business
2.21.3 Wockhardt Biosimilars Drug Product and Solutions
2.21.4 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Wockhardt Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilars Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biosimilars Drug by Company Revenue
3.2.2 Top 3 Biosimilars Drug Players Market Share in 2022
3.2.3 Top 6 Biosimilars Drug Players Market Share in 2022
3.3 Biosimilars Drug Market: Overall Company Footprint Analysis
3.3.1 Biosimilars Drug Market: Region Footprint
3.3.2 Biosimilars Drug Market: Company Product Type Footprint
3.3.3 Biosimilars Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilars Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biosimilars Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilars Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Biosimilars Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biosimilars Drug Consumption Value by Type (2018-2029)
6.2 North America Biosimilars Drug Consumption Value by Application (2018-2029)
6.3 North America Biosimilars Drug Market Size by Country
6.3.1 North America Biosimilars Drug Consumption Value by Country (2018-2029)
6.3.2 United States Biosimilars Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Biosimilars Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Biosimilars Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biosimilars Drug Consumption Value by Type (2018-2029)
7.2 Europe Biosimilars Drug Consumption Value by Application (2018-2029)
7.3 Europe Biosimilars Drug Market Size by Country
7.3.1 Europe Biosimilars Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.3 France Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Biosimilars Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Biosimilars Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilars Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biosimilars Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biosimilars Drug Market Size by Region
8.3.1 Asia-Pacific Biosimilars Drug Consumption Value by Region (2018-2029)
8.3.2 China Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.5 India Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biosimilars Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Biosimilars Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biosimilars Drug Consumption Value by Type (2018-2029)
9.2 South America Biosimilars Drug Consumption Value by Application (2018-2029)
9.3 South America Biosimilars Drug Market Size by Country
9.3.1 South America Biosimilars Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Biosimilars Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Biosimilars Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilars Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biosimilars Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biosimilars Drug Market Size by Country
10.3.1 Middle East & Africa Biosimilars Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Biosimilars Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biosimilars Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Biosimilars Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biosimilars Drug Market Drivers
11.2 Biosimilars Drug Market Restraints
11.3 Biosimilars Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilars Drug Industry Chain
12.2 Biosimilars Drug Upstream Analysis
12.3 Biosimilars Drug Midstream Analysis
12.4 Biosimilars Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilars Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biosimilars Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biosimilars Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biosimilars Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 6. Qilu Pharmaceutical Major Business
Table 7. Qilu Pharmaceutical Biosimilars Drug Product and Solutions
Table 8. Qilu Pharmaceutical Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Qilu Pharmaceutical Recent Developments and Future Plans
Table 10. Bio-Thera Company Information, Head Office, and Major Competitors
Table 11. Bio-Thera Major Business
Table 12. Bio-Thera Biosimilars Drug Product and Solutions
Table 13. Bio-Thera Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Thera Recent Developments and Future Plans
Table 15. Zhejiang Hisun Company Information, Head Office, and Major Competitors
Table 16. Zhejiang Hisun Major Business
Table 17. Zhejiang Hisun Biosimilars Drug Product and Solutions
Table 18. Zhejiang Hisun Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Zhejiang Hisun Recent Developments and Future Plans
Table 20. Shanghai Henlius Company Information, Head Office, and Major Competitors
Table 21. Shanghai Henlius Major Business
Table 22. Shanghai Henlius Biosimilars Drug Product and Solutions
Table 23. Shanghai Henlius Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Shanghai Henlius Recent Developments and Future Plans
Table 25. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 26. Innovent Biologics Major Business
Table 27. Innovent Biologics Biosimilars Drug Product and Solutions
Table 28. Innovent Biologics Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Innovent Biologics Recent Developments and Future Plans
Table 30. Jiangsu Hengrui Company Information, Head Office, and Major Competitors
Table 31. Jiangsu Hengrui Major Business
Table 32. Jiangsu Hengrui Biosimilars Drug Product and Solutions
Table 33. Jiangsu Hengrui Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Jiangsu Hengrui Recent Developments and Future Plans
Table 35. Gan&Lee Company Information, Head Office, and Major Competitors
Table 36. Gan&Lee Major Business
Table 37. Gan&Lee Biosimilars Drug Product and Solutions
Table 38. Gan&Lee Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Gan&Lee Recent Developments and Future Plans
Table 40. Tonghua Dongbao Company Information, Head Office, and Major Competitors
Table 41. Tonghua Dongbao Major Business
Table 42. Tonghua Dongbao Biosimilars Drug Product and Solutions
Table 43. Tonghua Dongbao Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Tonghua Dongbao Recent Developments and Future Plans
Table 45. United Laboratory Company Information, Head Office, and Major Competitors
Table 46. United Laboratory Major Business
Table 47. United Laboratory Biosimilars Drug Product and Solutions
Table 48. United Laboratory Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. United Laboratory Recent Developments and Future Plans
Table 50. 3SBIO Company Information, Head Office, and Major Competitors
Table 51. 3SBIO Major Business
Table 52. 3SBIO Biosimilars Drug Product and Solutions
Table 53. 3SBIO Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. 3SBIO Recent Developments and Future Plans
Table 55. Luye Pharma Company Information, Head Office, and Major Competitors
Table 56. Luye Pharma Major Business
Table 57. Luye Pharma Biosimilars Drug Product and Solutions
Table 58. Luye Pharma Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Luye Pharma Recent Developments and Future Plans
Table 60. Celltrion Company Information, Head Office, and Major Competitors
Table 61. Celltrion Major Business
Table 62. Celltrion Biosimilars Drug Product and Solutions
Table 63. Celltrion Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Celltrion Recent Developments and Future Plans
Table 65. Pfizer Company Information, Head Office, and Major Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Biosimilars Drug Product and Solutions
Table 68. Pfizer Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Pfizer Recent Developments and Future Plans
Table 70. Novartis Company Information, Head Office, and Major Competitors
Table 71. Novartis Major Business
Table 72. Novartis Biosimilars Drug Product and Solutions
Table 73. Novartis Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Novartis Recent Developments and Future Plans
Table 75. Dr Reddy’s Company Information, Head Office, and Major Competitors
Table 76. Dr Reddy’s Major Business
Table 77. Dr Reddy’s Biosimilars Drug Product and Solutions
Table 78. Dr Reddy’s Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Dr Reddy’s Recent Developments and Future Plans
Table 80. Celgen Biopharma Company Information, Head Office, and Major Competitors
Table 81. Celgen Biopharma Major Business
Table 82. Celgen Biopharma Biosimilars Drug Product and Solutions
Table 83. Celgen Biopharma Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Celgen Biopharma Recent Developments and Future Plans
Table 85. Eli Lilly Company Information, Head Office, and Major Competitors
Table 86. Eli Lilly Major Business
Table 87. Eli Lilly Biosimilars Drug Product and Solutions
Table 88. Eli Lilly Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly Recent Developments and Future Plans
Table 90. Sanofi Company Information, Head Office, and Major Competitors
Table 91. Sanofi Major Business
Table 92. Sanofi Biosimilars Drug Product and Solutions
Table 93. Sanofi Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Sanofi Recent Developments and Future Plans
Table 95. Geropharm Company Information, Head Office, and Major Competitors
Table 96. Geropharm Major Business
Table 97. Geropharm Biosimilars Drug Product and Solutions
Table 98. Geropharm Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Geropharm Recent Developments and Future Plans
Table 100. Biocon Company Information, Head Office, and Major Competitors
Table 101. Biocon Major Business
Table 102. Biocon Biosimilars Drug Product and Solutions
Table 103. Biocon Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Biocon Recent Developments and Future Plans
Table 105. Wockhardt Company Information, Head Office, and Major Competitors
Table 106. Wockhardt Major Business
Table 107. Wockhardt Biosimilars Drug Product and Solutions
Table 108. Wockhardt Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Wockhardt Recent Developments and Future Plans
Table 110. Global Biosimilars Drug Revenue (USD Million) by Players (2018-2023)
Table 111. Global Biosimilars Drug Revenue Share by Players (2018-2023)
Table 112. Breakdown of Biosimilars Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Biosimilars Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Biosimilars Drug Players
Table 115. Biosimilars Drug Market: Company Product Type Footprint
Table 116. Biosimilars Drug Market: Company Product Application Footprint
Table 117. Biosimilars Drug New Market Entrants and Barriers to Market Entry
Table 118. Biosimilars Drug Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Biosimilars Drug Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Biosimilars Drug Consumption Value Share by Type (2018-2023)
Table 121. Global Biosimilars Drug Consumption Value Forecast by Type (2024-2029)
Table 122. Global Biosimilars Drug Consumption Value by Application (2018-2023)
Table 123. Global Biosimilars Drug Consumption Value Forecast by Application (2024-2029)
Table 124. North America Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Biosimilars Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Biosimilars Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Biosimilars Drug Raw Material
Table 155. Key Suppliers of Biosimilars Drug Raw Materials
Table 1. Global Biosimilars Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biosimilars Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biosimilars Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biosimilars Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 6. Qilu Pharmaceutical Major Business
Table 7. Qilu Pharmaceutical Biosimilars Drug Product and Solutions
Table 8. Qilu Pharmaceutical Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Qilu Pharmaceutical Recent Developments and Future Plans
Table 10. Bio-Thera Company Information, Head Office, and Major Competitors
Table 11. Bio-Thera Major Business
Table 12. Bio-Thera Biosimilars Drug Product and Solutions
Table 13. Bio-Thera Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Thera Recent Developments and Future Plans
Table 15. Zhejiang Hisun Company Information, Head Office, and Major Competitors
Table 16. Zhejiang Hisun Major Business
Table 17. Zhejiang Hisun Biosimilars Drug Product and Solutions
Table 18. Zhejiang Hisun Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Zhejiang Hisun Recent Developments and Future Plans
Table 20. Shanghai Henlius Company Information, Head Office, and Major Competitors
Table 21. Shanghai Henlius Major Business
Table 22. Shanghai Henlius Biosimilars Drug Product and Solutions
Table 23. Shanghai Henlius Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Shanghai Henlius Recent Developments and Future Plans
Table 25. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 26. Innovent Biologics Major Business
Table 27. Innovent Biologics Biosimilars Drug Product and Solutions
Table 28. Innovent Biologics Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Innovent Biologics Recent Developments and Future Plans
Table 30. Jiangsu Hengrui Company Information, Head Office, and Major Competitors
Table 31. Jiangsu Hengrui Major Business
Table 32. Jiangsu Hengrui Biosimilars Drug Product and Solutions
Table 33. Jiangsu Hengrui Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Jiangsu Hengrui Recent Developments and Future Plans
Table 35. Gan&Lee Company Information, Head Office, and Major Competitors
Table 36. Gan&Lee Major Business
Table 37. Gan&Lee Biosimilars Drug Product and Solutions
Table 38. Gan&Lee Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Gan&Lee Recent Developments and Future Plans
Table 40. Tonghua Dongbao Company Information, Head Office, and Major Competitors
Table 41. Tonghua Dongbao Major Business
Table 42. Tonghua Dongbao Biosimilars Drug Product and Solutions
Table 43. Tonghua Dongbao Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Tonghua Dongbao Recent Developments and Future Plans
Table 45. United Laboratory Company Information, Head Office, and Major Competitors
Table 46. United Laboratory Major Business
Table 47. United Laboratory Biosimilars Drug Product and Solutions
Table 48. United Laboratory Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. United Laboratory Recent Developments and Future Plans
Table 50. 3SBIO Company Information, Head Office, and Major Competitors
Table 51. 3SBIO Major Business
Table 52. 3SBIO Biosimilars Drug Product and Solutions
Table 53. 3SBIO Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. 3SBIO Recent Developments and Future Plans
Table 55. Luye Pharma Company Information, Head Office, and Major Competitors
Table 56. Luye Pharma Major Business
Table 57. Luye Pharma Biosimilars Drug Product and Solutions
Table 58. Luye Pharma Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Luye Pharma Recent Developments and Future Plans
Table 60. Celltrion Company Information, Head Office, and Major Competitors
Table 61. Celltrion Major Business
Table 62. Celltrion Biosimilars Drug Product and Solutions
Table 63. Celltrion Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Celltrion Recent Developments and Future Plans
Table 65. Pfizer Company Information, Head Office, and Major Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Biosimilars Drug Product and Solutions
Table 68. Pfizer Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Pfizer Recent Developments and Future Plans
Table 70. Novartis Company Information, Head Office, and Major Competitors
Table 71. Novartis Major Business
Table 72. Novartis Biosimilars Drug Product and Solutions
Table 73. Novartis Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Novartis Recent Developments and Future Plans
Table 75. Dr Reddy’s Company Information, Head Office, and Major Competitors
Table 76. Dr Reddy’s Major Business
Table 77. Dr Reddy’s Biosimilars Drug Product and Solutions
Table 78. Dr Reddy’s Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Dr Reddy’s Recent Developments and Future Plans
Table 80. Celgen Biopharma Company Information, Head Office, and Major Competitors
Table 81. Celgen Biopharma Major Business
Table 82. Celgen Biopharma Biosimilars Drug Product and Solutions
Table 83. Celgen Biopharma Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Celgen Biopharma Recent Developments and Future Plans
Table 85. Eli Lilly Company Information, Head Office, and Major Competitors
Table 86. Eli Lilly Major Business
Table 87. Eli Lilly Biosimilars Drug Product and Solutions
Table 88. Eli Lilly Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly Recent Developments and Future Plans
Table 90. Sanofi Company Information, Head Office, and Major Competitors
Table 91. Sanofi Major Business
Table 92. Sanofi Biosimilars Drug Product and Solutions
Table 93. Sanofi Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Sanofi Recent Developments and Future Plans
Table 95. Geropharm Company Information, Head Office, and Major Competitors
Table 96. Geropharm Major Business
Table 97. Geropharm Biosimilars Drug Product and Solutions
Table 98. Geropharm Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Geropharm Recent Developments and Future Plans
Table 100. Biocon Company Information, Head Office, and Major Competitors
Table 101. Biocon Major Business
Table 102. Biocon Biosimilars Drug Product and Solutions
Table 103. Biocon Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Biocon Recent Developments and Future Plans
Table 105. Wockhardt Company Information, Head Office, and Major Competitors
Table 106. Wockhardt Major Business
Table 107. Wockhardt Biosimilars Drug Product and Solutions
Table 108. Wockhardt Biosimilars Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Wockhardt Recent Developments and Future Plans
Table 110. Global Biosimilars Drug Revenue (USD Million) by Players (2018-2023)
Table 111. Global Biosimilars Drug Revenue Share by Players (2018-2023)
Table 112. Breakdown of Biosimilars Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Biosimilars Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Biosimilars Drug Players
Table 115. Biosimilars Drug Market: Company Product Type Footprint
Table 116. Biosimilars Drug Market: Company Product Application Footprint
Table 117. Biosimilars Drug New Market Entrants and Barriers to Market Entry
Table 118. Biosimilars Drug Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Biosimilars Drug Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Biosimilars Drug Consumption Value Share by Type (2018-2023)
Table 121. Global Biosimilars Drug Consumption Value Forecast by Type (2024-2029)
Table 122. Global Biosimilars Drug Consumption Value by Application (2018-2023)
Table 123. Global Biosimilars Drug Consumption Value Forecast by Application (2024-2029)
Table 124. North America Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Biosimilars Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Biosimilars Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Biosimilars Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Biosimilars Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Biosimilars Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Biosimilars Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Biosimilars Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Biosimilars Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Biosimilars Drug Raw Material
Table 155. Key Suppliers of Biosimilars Drug Raw Materials
LIST OF FIGURES
Figure 1. Biosimilars Drug Picture
Figure 2. Global Biosimilars Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biosimilars Drug Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Insulin
Figure 6. Others
Figure 7. Global Biosimilars Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Biosimilars Drug Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Other Picture
Figure 12. Global Biosimilars Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Biosimilars Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Biosimilars Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Biosimilars Drug Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Biosimilars Drug Consumption Value Market Share by Region in 2022
Figure 17. North America Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Biosimilars Drug Revenue Share by Players in 2022
Figure 23. Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Biosimilars Drug Market Share in 2022
Figure 25. Global Top 6 Players Biosimilars Drug Market Share in 2022
Figure 26. Global Biosimilars Drug Consumption Value Share by Type (2018-2023)
Figure 27. Global Biosimilars Drug Market Share Forecast by Type (2024-2029)
Figure 28. Global Biosimilars Drug Consumption Value Share by Application (2018-2023)
Figure 29. Global Biosimilars Drug Market Share Forecast by Application (2024-2029)
Figure 30. North America Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. France Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Biosimilars Drug Consumption Value Market Share by Region (2018-2029)
Figure 47. China Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. India Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Biosimilars Drug Market Drivers
Figure 65. Biosimilars Drug Market Restraints
Figure 66. Biosimilars Drug Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Biosimilars Drug in 2022
Figure 69. Manufacturing Process Analysis of Biosimilars Drug
Figure 70. Biosimilars Drug Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Biosimilars Drug Picture
Figure 2. Global Biosimilars Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biosimilars Drug Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Insulin
Figure 6. Others
Figure 7. Global Biosimilars Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Biosimilars Drug Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Other Picture
Figure 12. Global Biosimilars Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Biosimilars Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Biosimilars Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Biosimilars Drug Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Biosimilars Drug Consumption Value Market Share by Region in 2022
Figure 17. North America Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Biosimilars Drug Revenue Share by Players in 2022
Figure 23. Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Biosimilars Drug Market Share in 2022
Figure 25. Global Top 6 Players Biosimilars Drug Market Share in 2022
Figure 26. Global Biosimilars Drug Consumption Value Share by Type (2018-2023)
Figure 27. Global Biosimilars Drug Market Share Forecast by Type (2024-2029)
Figure 28. Global Biosimilars Drug Consumption Value Share by Application (2018-2023)
Figure 29. Global Biosimilars Drug Market Share Forecast by Application (2024-2029)
Figure 30. North America Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. France Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Biosimilars Drug Consumption Value Market Share by Region (2018-2029)
Figure 47. China Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. India Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Biosimilars Drug Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Biosimilars Drug Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Biosimilars Drug Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Biosimilars Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Biosimilars Drug Market Drivers
Figure 65. Biosimilars Drug Market Restraints
Figure 66. Biosimilars Drug Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Biosimilars Drug in 2022
Figure 69. Manufacturing Process Analysis of Biosimilars Drug
Figure 70. Biosimilars Drug Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
